# HTG Molecular Diagnostics, Inc. (HTGMQ)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HTGMQ/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2023 | $ 1.12M | $ -5.47M | $ -4.72M | $ 3.98M | $ 474.5K |
| 2022 | $ 7.11M | $ -24.12M | $ -20.59M | $ 8.35M | $ 5.39M |
| 2021 | $ 10.59M | $ -20.38M | $ -20.39M | $ 11.71M | $ 10.40M |
| 2020 | $ 10.89M | $ -26.59M | $ -21.33M | $ 12.64M | $ 14.48M |
| 2019 | $ 24.79M | $ -24.91M | $ -22.97M | $ 11.25M | $ 23.97M |
| 2018 | $ 28.40M | $ -21.73M | $ -18.65M | $ 9.68M | $ 21.09M |
| 2017 | $ 19.88M | $ -25.54M | $ -23.70M | $ 8.75M | $ -3.06M |
| 2016 | $ 7.06M | $ -35.83M | $ -33.27M | $ 11.78M | $ -5.59M |
| 2015 | $ 5.67M | $ -30.04M | $ -28.90M | $ 10.85M | $ 16.89M |
| 2014 | $ 4.70M | $ -19.72M | $ -19.58M | $ 11.25M | $ -24.04M |
| 2013 | $ 2.40M | $ -13.88M | $ -4.14M | $ 44.1K | $ -22.45M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 8.39 |
| Liabilities / Eq | 21.90 |
| Current Ratio | 1.40 |

## Other views

- [Metrics](https://sponda.capital/en/HTGMQ.md)
- [Charts](https://sponda.capital/en/HTGMQ/charts.md)
- [Compare](https://sponda.capital/en/HTGMQ/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.